gp96, TLR and immunologic tolerance
gp96, TLR and immunologic tolerance
批准号:
8091738
负责人:
Zihai Li
金额:
$36.51万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-03-01 至 2014-02-28
关键词:
AddressAllelesAttentionAutoimmune DiseasesAutoimmune ProcessAutoimmunityAutomobile DrivingBindingBiochemicalBiologyCD4 Positive T LymphocytesCell surfaceCellsChronicClientComplexConfusionDNADefectDevelopmentDiseaseEndoplasmic ReticulumEpidemiologyFailureFamilyFundingGenerationsGeneticHeat shock proteinsHumanImmuneImmune ToleranceImmune systemImmunityImmunobiologyImmunologic Deficiency SyndromesImmunologicsImmunologistIn VitroInflammationInterleukin-10Interleukin-12InvestigationKDEL receptorLaboratoriesLigandsLocationLupusMaintenanceMalignant NeoplasmsMediatingMicrobeModelingMolecular ChaperonesMusNucleic AcidsNull LymphocytesPathogenesisPhenocopyPhenotypePropertyProteinsRegulationRoleSignal TransductionSurfaceSystemSystemic Lupus ErythematosusT-LymphocyteTLR2 geneTLR5 geneTLR7 geneTNFRSF11B geneTransgenic MiceTransplantationcell typeclinically relevantcommensal microbescytokineextracellularin vivointerleukin-23lupus-likeoverexpressionperipheral tolerancepreventpublic health relevanceresponsestress proteintoll-like receptor 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Heat shock protein gp96 is a key downstream chaperone in the endoplasmic reticulum (ER) that mediates ER unfolded protein responses (UPR). Cell surface expression of gp96 in a transgenic mouse leads to spontaneous lupus-like autoimmune disease which is dependent on commensal bacteria and Toll-like receptor 4 (TLR4). This finding, together with the discovery that gp96 is a master chaperone for TLRs, has moved the field forward significantly: we now hypothesize that gp96 tunes the immune system by chaperoning TLRs but not by signaling through TLRs; depending on its expression level and location, gp96 can break tolerance if upregulated and can confer immunodeficiency if compromised in expression or function. The previously unappreciated roles of TLR4 in lupus have been validated by lupus in TLR4-overexpressing mice. Studies of the mechanism of autoimmunity in gp96 transgenic mice have also uncovered the potential impact of chronic TLR hyperresponsiveness to commensal flora on IL-10-producing CD4? T cells (TR1) and IL-17-secreting CD4 cells (TH17) in vivo. In this proposal, we will critically address the hypothesis that TLR4 amplification at either DNA level or post translational level significantly impact the biology (priming, maintenance and function) of both TR1 and TH17, leading to breakdown of peripheral tolerance. We will also define the hierarchy of TLRs in driving lupus with particular focus on the roles of nucleic acid-sensing TLRs in our model. Our study is of fundamental significance in understanding the roles of TLRs in immunity and tolerance via regulating TR1 and TH17, since the dysregulation of these cell types has been increasingly implicated in autoimmune diseases. Our recent findings that the surface expression of gp96 is highly regulated in vivo and that the increased expression of gp96 on the cell surface correlates with human lupus highlight the clinical relevance of our study.
PUBLIC HEALTH RELEVANCE: This project addresses the mechanism of lupus, which has implications in the understanding of general immunobiology, cancer immunity and other autoimmune diseases. We aim to prove the hypothesis that the overexpression of particular cell surface stress proteins leads to heightened responses against microbes, which in turn triggers the development of autoimmunity through complex actions on two critical immune regulatory cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
-
批准号:10629078
-
项目类别:
-
资助金额:$53.14万
-
财政年份:2023
-
负责人:Zihai Li
-
依托单位:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy Supplement
-
批准号:10818173
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2021
-
负责人:Zihai Li
-
依托单位:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
-
批准号:10474548
-
项目类别:
-
资助金额:$59.43万
-
财政年份:2021
-
负责人:Zihai Li
-
依托单位:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
-
批准号:10689068
-
项目类别:
-
资助金额:$53.79万
-
财政年份:2021
-
负责人:Zihai Li
-
依托单位:
Targeting GRP94-TGF-beta Pathway for Cancer Immunotherapy
-
批准号:10275810
-
项目类别:
-
资助金额:$56.92万
-
财政年份:2021
-
负责人:Zihai Li
-
依托单位:
Integration of inflammation and cancer by molecular chaperone
-
批准号:10056559
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2017
-
负责人:Zihai Li
-
依托单位:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
-
批准号:9321008
-
项目类别:
-
资助金额:$133.53万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Project 1: Definition of grp94-GARP-TGFbeta Axis in Cancer Biology and Clinical Significance
-
批准号:8934513
-
项目类别:
-
资助金额:$22.38万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease
-
批准号:9026108
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
-
批准号:8934510
-
项目类别:
-
资助金额:$133.75万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
-
批准号:9770790
-
项目类别:
-
资助金额:$135.49万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Thrombocytes in Cancer Immunity
-
批准号:9235264
-
项目类别:
-
资助金额:$38.72万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Endoplasmic Reticulum Chaperones in Cancer Biology and Therapy
-
批准号:9135256
-
项目类别:
-
资助金额:$138.52万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Novel mechanisms of UPR sensing and nonalcoholic fatty liver disease
-
批准号:9190367
-
项目类别:
-
资助金额:$33.64万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Thrombocytes in Cancer Immunity
-
批准号:10047658
-
项目类别:
-
资助金额:$22.51万
-
财政年份:2015
-
负责人:Zihai Li
-
依托单位:
Novel Chaperone Mechanism for Platelet Disorder
-
批准号:7934003
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Zihai Li
-
依托单位:
Molecular chaperones and immune tolerance
-
批准号:9440331
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2009
-
负责人:Zihai Li
-
依托单位:
Molecular chaperones and immune tolerance
-
批准号:9310818
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2009
-
负责人:Zihai Li
-
依托单位:
gp96, TLR and immunologic tolerance
-
批准号:8029526
-
项目类别:
-
资助金额:$36.14万
-
财政年份:2009
-
负责人:Zihai Li
-
依托单位:
Molecular chaperones and immune tolerance
-
批准号:10112807
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2009
-
负责人:Zihai Li
-
依托单位:
海外基金